143 related articles for article (PubMed ID: 9615200)
1. Molecular prognostic factors in bladder cancer.
Schalken JA
Eur Urol; 1998; 33 Suppl 4():13-4. PubMed ID: 9615200
[No Abstract] [Full Text] [Related]
2. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
[TBL] [Abstract][Full Text] [Related]
3. The prognostic value of p53 in superficially infiltrating transitional cell carcinoma.
Vatne V; Maartmann-Moe H; Hoestmark J
Scand J Urol Nephrol; 1995 Dec; 29(4):491-5. PubMed ID: 8719368
[TBL] [Abstract][Full Text] [Related]
4. [Prognostic factors in urothelial carcinoma].
Vögeli TA; Ackermann R
Urologe A; 2001 Nov; 40(6):442-6. PubMed ID: 11760346
[TBL] [Abstract][Full Text] [Related]
5. [Use of silicon chip technology to detect protein-based tumor markers in bladder cancer].
Jäger T; Szarvas T; vom Dorp F; Börgermann C; Schenck M; Schmid KW; Rübben H
Urologe A; 2007 Sep; 46(9):1152-6. PubMed ID: 17593336
[TBL] [Abstract][Full Text] [Related]
6. Cell cycle regulators as prognostic factors for bladder cancer.
Cordon-Cardo C
Eur Urol; 1998; 33 Suppl 4():11-2. PubMed ID: 9615199
[No Abstract] [Full Text] [Related]
7. [Carcinoembryonic antigen in tumor tissue and urine in cases with primary bladder cancer--a study by immunogold-silver staining and radioimmunoassay].
Kawano S
Nihon Hinyokika Gakkai Zasshi; 1988 Mar; 79(3):469-74. PubMed ID: 2464713
[No Abstract] [Full Text] [Related]
8. [Is protein p53 an independent prognostic factor in bladder carcinoma?].
Keilholz L
Strahlenther Onkol; 1995 Sep; 171(9):543-4. PubMed ID: 7570304
[No Abstract] [Full Text] [Related]
9. Urinary markers for urothelial cancer.
Sözen S; Eskicorabci S; Ozen H
BJU Int; 2003 Oct; 92(6):531-3. PubMed ID: 14511027
[No Abstract] [Full Text] [Related]
10. Urothelial Carcinoma With Villoglandular Differentiation: A Rare Entity.
Mitra S; Sundaram AK; Gupta K; Devana SK
Int J Surg Pathol; 2016 Jun; 24(4):356-9. PubMed ID: 26721305
[TBL] [Abstract][Full Text] [Related]
11. Expression of epidermal growth factor receptor in bladder cancer as related to established prognostic factors, oncoprotein (c-erbB-2, p53) expression and long-term prognosis.
Lipponen P; Eskelinen M
Br J Cancer; 1994 Jun; 69(6):1120-5. PubMed ID: 7911031
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of p53, p21/WAF1, Bcl-2, Bax, Bak and Ki-67 immunoreactivity in pT1 G3 urothelial bladder carcinomas.
Wolf HK; Stöber C; Hohenfellner R; Leissner J
Tumour Biol; 2001; 22(5):328-36. PubMed ID: 11553864
[TBL] [Abstract][Full Text] [Related]
13. p53 overexpression as a prognostic factor for advanced stage bladder cancer.
Kuczyk MA; Bokemeyer C; Serth J; Hervatin C; Oelke M; Höfner K; Tan HK; Jonas U
Eur J Cancer; 1995 Dec; 31A(13-14):2243-7. PubMed ID: 8652250
[TBL] [Abstract][Full Text] [Related]
14. p53 and bladder cancer.
Xing X
N Engl J Med; 1995 Apr; 332(14):957-8. PubMed ID: 7877657
[No Abstract] [Full Text] [Related]
15. p53 and bladder cancer.
Li WW; Li VW; Tsakayannis D
N Engl J Med; 1995 Apr; 332(14):957; author reply 958. PubMed ID: 7794332
[No Abstract] [Full Text] [Related]
16. Biomarkers for transitional cell carcinoma-pro.
Grossman HB
Urology; 2001 May; 57(5):847-8. PubMed ID: 11337279
[No Abstract] [Full Text] [Related]
17. Expression of p21(waf1/cip1) protein in transitional cell bladder tumours and its prognostic value.
Lipponen P; Aaltomaa S; Eskelinen M; Ala-Opas M; Kosma VM
Eur Urol; 1998 Sep; 34(3):237-43. PubMed ID: 9732201
[TBL] [Abstract][Full Text] [Related]
18. Cellular proliferation and cell-cell cycle regulatory proteins as prognostic markers for transitional cell carcinoma of the bladder.
Grossfeld GD; Muscheck M; Stein JP; Chew K; Cote RJ; Ginsberg DA; Waldman FM; Carroll PR
Adv Exp Med Biol; 1999; 462():425-35. PubMed ID: 10599445
[No Abstract] [Full Text] [Related]
19. p53 and bladder cancer.
Wood LL
N Engl J Med; 1995 Apr; 332(14):958. PubMed ID: 7877658
[No Abstract] [Full Text] [Related]
20. Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: a marker for disease progression.
Sarkis AS; Dalbagni G; Cordon-Cardo C; Zhang ZF; Sheinfeld J; Fair WR; Herr HW; Reuter VE
J Natl Cancer Inst; 1993 Jan; 85(1):53-9. PubMed ID: 7677935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
